Cargando…

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

Neuroprotective treatments in Parkinson's disease (PD) have remained elusive. Psychotropics are commonly prescribed in PD without regard to their pathobiological effects. The authors investigated the effects of psychotropics on pathobiological proteins, proteasomal activity, mitochondrial funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauterbach, Edward C., Fontenelle, Leonardo F., Teixeira, Antonio L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255316/ https://www.ncbi.nlm.nih.gov/pubmed/22254151 http://dx.doi.org/10.1155/2012/753548

Ejemplares similares

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
por: Lauterbach, Edward C.
Publicado: (2013)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010)

The neurotrophic and neuroprotective effects of psychotropic agents
por: Hunsberger, Joshua, et al.
Publicado: (2009)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
por: C. Gonçalves, Valeria, et al.
Publicado: (2020)

On Disease Modifying and Neuroprotective Treatments for Parkinson's Disease: Physical Exercise
por: Garcia Ruiz, Pedro J., et al.
Publicado: (2022)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Psychiatric disorders in primary focal dystonia and in Parkinson’s disease
por: Dias, Fernando MV, et al.
Publicado: (2011)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Psychotropic medication use and Parkinson's disease risk amongst older women
por: Beydoun, Hind A., et al.
Publicado: (2022)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010)

Neuroprotective potential of Beta vulgaris L. in Parkinson's disease
por: Nade, Vandana S., et al.
Publicado: (2015)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
por: Carrera, Iván, et al.
Publicado: (2019)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
por: Kabra, Atul, et al.
Publicado: (2020)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
por: Marashly, Eyad T., et al.
Publicado: (2017)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
por: Torres, Napoleon, et al.
Publicado: (2017)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature
por: Nebrisi, Eslam El
Publicado: (2021)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
por: Hu, Xinyu, et al.
Publicado: (2023)

Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson’s disease
por: Alarcón, Tamara Andrea, et al.
Publicado: (2022)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity
por: Telles-Correia, Diogo, et al.
Publicado: (2017)

Potential Molecular and Cellular Mechanism of Psychotropic Drugs
por: Seo, Myoung Suk, et al.
Publicado: (2014)

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
por: Sportelli, Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0evvr0sish4th1u2ct13v81gq